.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Moodys
Harvard Business School
Federal Trade Commission
Johnson and Johnson
Citi
Argus Health
Novartis
US Department of Justice
Cantor Fitzgerald

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018920

« Back to Dashboard
NDA 018920 describes M.V.I. PEDIATRIC, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the M.V.I. PEDIATRIC profile page.

The generic ingredient in M.V.I. PEDIATRIC is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.

Summary for NDA: 018920

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1